Compounds > 6-ketoprostaglandin-f1-alpha

6-ketoprostaglandin-f1-alpha and Neoplasms--Germ-Cell-and-Embryonal

6-ketoprostaglandin-f1-alpha has been researched along with Neoplasms--Germ-Cell-and-Embryonal* in 1 studies

Other Studies

1 other study(ies) available for 6-ketoprostaglandin-f1-alpha and Neoplasms--Germ-Cell-and-Embryonal

Article	Year
Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells. Advances in experimental medicine and biology, 1996, Volume: 416 Our data suggest non-specific Paf binding to intact embryonal F9 cells. Non-specific Paf binding might have some physiological relevance when Paf metabolites interfere with prostacyclin synthesis, for example, in umbilical vein endothelial cells. Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Carcinoma, Embryonal; Cell Line; Embryo, Mammalian; Endothelium, Vascular; Epoprostenol; Humans; Mice; Neoplasms, Germ Cell and Embryonal; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Umbilical Veins	1996

Article

Year

Non-specific PAF binding to embryonal F9 cells and prostacyclin synthesis in human umbilical vein endothelial cells.

Advances in experimental medicine and biology, 1996, Volume: 416

Our data suggest non-specific Paf binding to intact embryonal F9 cells. Non-specific Paf binding might have some physiological relevance when Paf metabolites interfere with prostacyclin synthesis, for example, in umbilical vein endothelial cells.

Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Carcinoma, Embryonal; Cell Line; Embryo, Mammalian; Endothelium, Vascular; Epoprostenol; Humans; Mice; Neoplasms, Germ Cell and Embryonal; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Umbilical Veins

1996